SEQUASE XR cpr ret 150 mg 100 pce
7680632550031
CH-63255
N05AH04
01.05.0.
Active substances:
1 / 3
google
Details
- Product number
- 6325502
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- quetiapinum 150 mg ut quetiapini fumaras 172.69 mg, lactosum monohydricum 74.65 mg, cellulosum microcristallinum, natrii citras dihydricus corresp. natrium 16.857 mg, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, pro compresso obducto.
Articles (1)
Sequase XR 150 mg, Retardtabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
quetiapinum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
quetiapini fumaras
|
172.69 MG | Substance | WIZUS |
|
lactosum monohydricum
|
74.65 MG | Substance | HBESI |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrium
|
16.857 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
E 171
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 122.20
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2015
Authorization holder
Cheplapharm Schweiz GmbH
4102 Binningen
Authorization information
- Swissmedic authorization number
- 63255
- Drug name
- Sequase XR, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05AH04
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 01/10/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SEQUASE XR cpr ret 150 mg 100 pce
- Description (DE)
- SEQUASE XR Ret Tabl 150 mg 100 Stk
- Market launch
- 01/10/2013
- Narcotic (BTM)
- No